Can urine osteopontin levels, which may be correlated with nutrition intake and body composition, be used as a new biomarker in the diagnosis of nephrolithiasis?

Clinical Biochemistry

Volumn 60, Issue , 2018, Pages 38-43

  Icer, Mehmet Arif ^a   Gezmen Karadag, Makbule ^a   Sozen, Sinan ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Biomarker; Body composition; Creatinine; Dietary effects; Nephrolithiasis; Osteopontin

Indexed keywords

BIOLOGICAL MARKER; CREATININE; OMEGA 6 FATTY ACID; OSTEOPONTIN; POLYUNSATURATED FATTY ACID;

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIETARY INTAKE; FAT INTAKE; FEMALE; FLUID INTAKE; FOOD FREQUENCY QUESTIONNAIRE; HIP CIRCUMFERENCE; HUMAN; MALE; MUSCLE MASS; NEPHROLITHIASIS; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; WAIST CIRCUMFERENCE; BLOOD; DIET; MIDDLE AGED; URINE; YOUNG ADULT;

ADULT; AGED; BIOMARKERS; BODY COMPOSITION; CREATININE; DIET; FEMALE; HUMANS; MALE; MIDDLE AGED; NEPHROLITHIASIS; NUTRITIONAL STATUS; OSTEOPONTIN; YOUNG ADULT;

EID: 85052052820     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2018.08.001     Document Type: Article

References (40)

1. Moe, O.W., Kidney stones: pathophysiology and medical management. Lancet 367:9507 (2006), 333–344.
2. Barbas, C., Garcıa, A., Saavedra, L., Muros, M., Urinary analysis of nephrolithiasis markers. J. Chromatogr. B 781:1 (2002), 433–455.
3. Bihl, G., Meyers, A., Recurrent renal stone disease—advances in pathogenesis and clinical management. Lancet 358:9282 (2001), 651–656.
4. Narter F, Sarıca K: Üriner Sistem Taş Hastalığının Biyomoleküler Mekanizması.
5. EREK, E., Erek Nefroloji. 6 edn., 2010, Nobel Tip Kitabevleri, Istanbul.
6. Icer, M.A., Gezmen-Karadag, M., The multiple functions and mechanisms of osteopontin. Clin. Biochem. 59 (2018), 17–24.
7. Wesson, J.A., Johnson, R.J., Mazzali, M., Beshensky, A.M., Stietz, S., Giachelli, C., Liaw, L., Alpers, C.E., Couser, W.G., Kleinman, J.G., Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J. Am. Soc. Nephrol. 14:1 (2003), 139–147.
8. Yasui, T., Fujita, K., Hayashi, Y., Ueda, K., Kon, S., Maeda, M., Uede, T., Kohri, K., Quantification of osteopontin in the urine of healthy and stone-forming men. Urol. Res. 27:4 (1999), 225–230.
9. Liu, C.-C., Huang, S.-P., Tsai, L.-Y., Wu, W.-J., Juo, S.-H.H., Chou, Y.-H., Huang, C.-H., Wu, M.-T., The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin. Chim. Acta 411:9-10 (2010), 739–743.
10. Yaman, F., Aybek, H., Aybek, Z., Üriner sistem taş hastalığı etiyopatogenezinde fetuin-a ve osteopotin. 2011, Pamukkale Üniversitesi.
11. Okada, A., Nomura, S., Saeki, Y., Higashibata, Y., Hamamoto, S., Hirose, M., Itoh, Y., Yasui, T., Tozawa, K., Kohri, K., Morphological conversion of calcium oxalate crystals into stones is regulated by osteopontin in mouse kidney. J. Bone Miner. Res. 23:10 (2008), 1629–1637.
12. Hamamoto, S., Yasui, T., Okada, A., Hirose, M., Matsui, Y., Kon, S., Sakai, F., Kojima, Y., Hayashi, Y., Tozawa, K., Crucial role of the cryptic epitope SLAYGLR within osteopontin in renal crystal formation of mice. J. Bone Miner. Res. 26:12 (2011), 2967–2977.
13. Hirose, M., Tozawa, K., Okada, A., Hamamoto, S., Higashibata, Y., Gao, B., Hayashi, Y., Shimizu, H., Kubota, Y., Yasui, T., Role of osteopontin in early phase of renal crystal formation: immunohistochemical and microstructural comparisons with osteopontin knock-out mice. Urol. Res. 40:2 (2012), 121–129.
14. Wang, X., Cheng, M., Zhao, M., Ge, A., Guo, F., Zhang, M., Yang, Y., Liu, L., Yang, N., Differential effects of high-fat-diet rich in lard oil or soybean oil on osteopontin expression and inflammation of adipose tissue in diet-induced obese rats. Eur. J. Nutr. 52:3 (2013), 1181–1189.
15. Singh, A., Pezeshki, A., Zapata, R.C., Yee, N.J., Knight, C.G., Tuor, U.I., Chelikani, P.K., Diets enriched in whey or casein improve energy balance and prevent morbidity and renal damage in salt-loaded and high-fat-fed spontaneously hypertensive stroke-prone rats. J. Nutr. Biochem. 37 (2016), 47–59.
16. Matsuzaki, H., Masuyama, R., Uehara, M., Nakamura, K., Suzuki, K., Greater Effect of Dietary Potassium Tripolyphoshate than of Potassium Dihydrogenphosphate on the Nephrocalcinosis and Proximal Tubular Function in Female Rats from the Intake of a High-phosphorus Diet. Biosci. Biotechnol. Biochem. 65:4 (2001), 928–934.
17. Penczynski, K.J., Krupp, D., Bring, A., Bolzenius, K., Remer, T., Buyken, A.E., Relative validation of 24-h urinary hippuric acid excretion as a biomarker for dietary flavonoid intake from fruit and vegetables in healthy adolescents. Eur. J. Nutr. 56:2 (2017), 757–766.
18. Ferraro, P.M., Taylor, E.N., Gambaro, G., Curhan, G.C., Soda and other beverages and the risk of kidney stones. Clin. J. Am. Soc. Nephrol. 8:8 (2013), 1389–1395.
19. Siener, R., Glatz, S., Nicolay, C., Hesse, A., The role of overweight and obesity in calcium oxalate stone formation. Obes. Res. 12:1 (2004), 106–113.
20. Taylor, E.N., Stampfer, M.J., Curhan, G.C., Obesity, weight gain, and the risk of kidney stones. JAMA 293:4 (2005), 455–462.
21. PEKCAN, G., El Kitabi, Diyet, (eds.) Beslenme Durumunun Saptanması, 6 edn., 2011, HATİBOĞLU YAYINLARI, ANKARA, 67–142.
22. Rakıcıoğlu, N., Acar Tek, N., Ayaz, A., Pekcan, G., Yemek ve besin fotoğraf kataloğu. Hatiboğlu Yayınevi, 1, 2012.
23. BeBis (Beslenme Bilgi Sistemi) bilgisayar yazılım programı versiyon 7. In.
24. https://www.cusabio.com/ELISA-Kit/Human-OsteopontinOPN-ELISA-Kit-105826.html.
25. Coe, F.L., Evan, A., Worcester, E., Kidney stone disease. J. Clin. Invest. 115:10 (2005), 2598–2608.
26. Curhan, G., Willett, W., Rimm, E., Stampfer, M., Family history and risk of kidney stones. J. Urol., 162(2), 1999, 635.
27. Zeng, G., Mai, Z., Xia, S., Wang, Z., Zhang, K., Wang, L., Long, Y., Ma, J., Li, Y., Wan, S.P., Prevalence of kidney stones in China: an ultrasonography based cross-sectional study. BJU Int. 120:1 (2017), 109–116.
28. Jabbar, F., Asif, M., Dutani, H., Hussain, A., Malik, A., Kamal, M.A., Rasool, M., Assessment of the role of general, biochemical and family history characteristics in kidney stone formation. Saudi J. Biol. Sci. 22:1 (2015), 65–68.
29. Atuğ F, Canoruç N: Tekrarlayan Üriner Sistem Kalsiyum Taşlarının Metabolik Değerlendirmesi ve Medikal Yaklaşımlar.
30. Meschi, T., Nouvenne, A., Ticinesi, A., Prati, B., Guerra, A., Allegri, F., Pigna, F., Soldati, L., Vezzoli, G., Gambaro, G., Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. J. Transl. Med., 10(1), 2012, 63.
31. Taşdemir, M., Fuçucuoğlu, D., Küçük, S.H., Erol, M., Yiğit, Ö., Bilge, I., Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis. Clin. Exp. Nephrol., 2017, 1–9.
32. Asplin, J.R., Arsenault, D., Parks, J.H., Coe, F.L., Hoyer, J.R., Contribution of human uropontin to inhibition of calcium oxalate crystallization. Kidney Int. 53:1 (1998), 194–199.
33. Kleinman, J.G., Beshensky, A., Worcester, E.M., Brown, D., Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int. 47:6 (1995), 1585–1596.
34. Hudkins, K.L., Giachelli, C.M., Cui, Y., Couser, W.G., Johnson, R.J., Alpers, C.E., Osteopontin expression in fetal and mature human kidney. J. Am. Soc. Nephrol. 10:3 (1999), 444–457.
35. Gómez-Ambrosi, J., Catalán, V., Ramírez, B., Rodríguez, A., Colina, I., Silva, C., Rotellar, F., Mugueta, C., Gil, M.J., Cienfuegos, J.A., Plasma osteopontin levels and expression in adipose tissue are increased in obesity. J. Clin. Endocrinol. Metabol. 92:9 (2007), 3719–3727.
36. Lee, O.K., Shih, Y.-Y., Liu, Y.-S., Liu, Y.-A., Tsao, Y.-T., Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells. Stem Cell Res Ther, 8(1), 2017, 39.
37. Lee, S.-Y., Lee, S.-J., Piao, H.-L., Yang, S.-Y., Weiner, I.D., Kim, J., Han, K.-H., Hydration status affects osteopontin expression in the rat kidney. J. Vet. Sci. 17:3 (2016), 269–277.
38. Pestka, J.J., Vines, L.L., Bates, M.A., He, K., Langohr, I., Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and CD4+ T cell-related gene responses in the autoimmune NZBWF1 mouse. PLoS One, 9(6), 2014, e100255.
39. Stienstra, R., Duval, C., Keshtkar, S., van der Laak, J., Kersten, S., Müller, M., Peroxisome proliferator-activated receptor γ activation promotes infiltration of alternatively activated macrophages into adipose tissue. J. Biol. Chem. 283:33 (2008), 22620–22627.
40. Shirakawa, K., Endo, J., Katsumata, Y., Yamamoto, T., Kataoka, M., Isobe, S., Yoshida, N., Fukuda, K., Sano, M., Negative legacy of obesity. PLoS One, 12(10), 2017, e0186303.